Marketing-authorisation holder · Sweden
Astrazeneca Ab
179 medicines in 3 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Sweden
179 medicines in 3 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 179
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Bevespi Aerosphere | Glycopyrronium, Formoterol | EU (EMA) | Authorised | 2018 |
| Brilique | Ticagrelor | EU (EMA) | Authorised | 2010 |
| BRILIQUE 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA60 mg · Comprimido recubierto con película | Ticagrelor | Spain | Authorised | 2016 |
| BRILIQUE 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA60 mg · Comprimido recubierto con película | Ticagrelor | Spain | Marketed | 2016 |
| BRILIQUE 90 MG COMPRIMIDOS BUCODISPERSABLES90 mg · Comprimido bucodispersable | Ticagrelor | Spain | Marketed | 2017 |
| BRILIQUE 90 MG COMPRIMIDOS RECUBIERTOS CON PELICULA90 mg · Comprimido recubierto con película | Ticagrelor | Spain | Marketed | 2011 |
| BRILIQUE 90 MG COMPRIMIDOS RECUBIERTOS CON PELICULA90 mg · Comprimido recubierto con película | Ticagrelor | Spain | Marketed | 2011 |
| Bydureon | Exenatide | EU (EMA) | Authorised | 2011 |
| Byetta | Exenatide | EU (EMA) | Authorised | 2006 |
| Calquence | Acalabrutinib | EU (EMA) | Authorised | 2020 |
| CALQUENCE 100 MG CAPSULAS DURAS100 mg · Cápsula dura | Acalabrutinib | Spain | Authorised | 2020 |
| CALQUENCE 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA129 mg · Comprimido recubierto con película | Acalabrutinib | Spain | Marketed | 2023 |
| CALQUENCE 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA129 mg · Comprimido recubierto con película | Acalabrutinib | Spain | Marketed | 2025 |
| CALQUENCE 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA129 mg · Comprimido recubierto con película | Acalabrutinib | Spain | Authorised | 2026 |
| CRESTOR 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA10 mg · Comprimido recubierto con película | Rosuvastatin | Spain | Authorised | 2020 |
| Daxas | Roflumilast | EU (EMA) | Authorised | 2010 |
| DAXAS 250 MICROGRAMOS COMPRIMIDOS250 µg · Comprimido | Roflumilast | Spain | Marketed | 2019 |
| DAXAS 500 MICROGRAMOS COMPRIMIDOS RECUBIERTOS CON PELICULA500 µg · Comprimido recubierto con película | Roflumilast | Spain | Marketed | 2010 |
| Ebymect | Dapagliflozin, Metformin | EU (EMA) | Authorised | 2015 |
| EBYMECT 5 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA5 mg + 1005 mg · Comprimido recubierto con película | Dapagliflozin, Metformin | Spain | Marketed | 2015 |
| EBYMECT 5 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA5 mg + 854 mg · Comprimido recubierto con película | Dapagliflozin, Metformin | Spain | Marketed | 2015 |
| Edistride | Dapagliflozin | EU (EMA) | Authorised | 2015 |
| EDISTRIDE 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA10 mg · Comprimido recubierto con película | Dapagliflozin | Spain | Marketed | 2015 |
| EDISTRIDE 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA6.150 mg · Comprimido recubierto con película | Dapagliflozina propanodiol | Spain | Authorised | 2019 |
| Fasenra | Benralizumab | EU (EMA) | Authorised | 2018 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 85 | 71 | 14 | CompaniesAll medicines |
| Romania | 49 | 0 | 49 | CompaniesAll medicines |
| European Union (EMA) | 45 | 32 | 13 | CompaniesAll medicines |
Also in the registers of Brazil, Croatia, France, Italy, Netherlands, Saudi Arabia, Serbia, Singapore, United States
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.